News

Camena Bioscience Raises $10 Million to Pursue DNA Synthesis Technology

July 07, 2023

Camena Bioscience has completed $10 million in Series A financing on the back of growing demand for DNA synthesis.

Thermo Fisher Scientific Releases Tumoroid Culture Medium Kit

July 07, 2023

Thermo Fisher Scientific’s new tumoroid culture medium kit is designed to help cancer researchers better model the disease.

Eurofins Genomics Blue Heron Launches In-Vitro Transcription mRNA Synthesis Service

July 07, 2023

Eurofins Genomics Blue Heron’s novel mRNA synthesis service is designed for customizable applications.

Europe Phases Out COVID-19 Flexible Regulations

July 06, 2023

EMA, the European Commission, and HMAs are phasing out the flexible regulations put into place during the pandemic.

COVID-19 Vaccine, Nuvaxovid, Gains EU Approval

July 06, 2023

Full Marketing Authorization has been granted for Novavax’s COVID-19 vaccine by the European Commission.

Chime Biologics Forms mAb Development and Manufacturing Deal with Leads Biolabs and BeiGene

July 06, 2023

Chime Biologics, Leads Biolabs, and BeiGene have formed a three-way collaboration to advance the development and global manufacturing of Leads Biolabs’ lead mAb candidate, LBL-007.

Meletios Therapeutics’ Efforts in Antiviral Field Gains Recognition from Bpifrance

July 06, 2023

Meletios Therapeutics has been awarded with funding worth €1.2 million (US$1.3 million) from Bpifrance’s Deeptech development program.

Syngene Adds Biologics Drug Substance Manufacturing Capacity with Facility Acquisition

July 06, 2023

Syngene has acquired a multi-modal biologics drug substance manufacturing facility in Bangalore, India, from Stelis Biopharma.

FDA Approves BioMarin’s Roctavian, the First Gene Therapy for Treating Severe Hemophilia A

July 05, 2023

FDA has approved Roctavian (valoctocogene roxaparvovec-rvox), a gene therapy from BioMarin Pharmaceutical for treating severe hemophilia A in adults.

New Deal on the Horizon

July 02, 2023

The UK and EU have negotiated a new draft deal for Britain to re-join the Horizon Europe research programme.